Discuss This Disease

4 free views remaining today

myoclonic dystonia 26

Description

Myoclonic Dystonia: A Rare Movement Disorder

Myoclonic dystonia, also known as myoclonus-dystonia syndrome, is a rare movement disorder that affects the muscles. It is characterized by sudden, brief muscle jerks or twitches (myoclonus)

Additional Characteristics

  • twitches
  • sudden
  • brief
  • muscle
  • jerks

Signs and Symptoms

Based on the provided context, here are the signs and symptoms of myoclonic dystonia:

Common Symptoms

  • Rapid, brief muscle contractions (myoclonus) [2]
  • Distortion of the body's orientation due to involuntary movements [6]
  • Involuntary muscle jerking or twitching (myoclonus), usually affecting the upper body [7]

Additional Symptoms

  • Vomiting
  • Choking
  • Confusion
  • Slow or irregular breathing
  • Pale or blue-tinged skin
  • Seizures
  • Low body temperature
  • A "dragging leg"
  • Cramping of your foot
  • Involuntary pulling of your neck
  • Uncontrollable blinking
  • Trouble speaking [8][9]

Please note that these symptoms may vary from person to person, and not everyone with myoclonic dystonia will experience all of them.

Additional Symptoms

  • Seizures
  • Low body temperature
  • Uncontrollable blinking
  • Trouble speaking
  • Choking
  • Slow or irregular breathing
  • Pale or blue-tinged skin
  • Rapid, brief muscle contractions (myoclonus)
  • Distortion of the body's orientation due to involuntary movements
  • Involuntary muscle jerking or twitching (myoclonus), usually affecting the upper body
  • A 'dragging leg'
  • Cramping of your foot
  • Involuntary pulling of your neck
  • vomiting
  • confusion

Diagnostic Tests

Based on the provided context, it appears that you are looking for information on diagnostic tests for myoclonic dystonia.

According to the search results, laboratory tests may be suggested by a healthcare provider to help identify possible causes of myoclonus. These tests include:

  • Blood or urine tests [10]
  • Genetic testing to help identify possible causes of myoclonus [10]

Additionally, electrophysiological tests can be helpful in determining whether myoclonus is cortical, subcortical, or spinal [13]. Treatment plans are individualized to a patient's presenting symptoms and may include benzodiazepines (clonazepam) and antiepileptic drugs (valproate, levetiracetam) [12].

It's also worth noting that a thorough patient history and examination are needed to establish the clinical diagnosis of dystonia, followed by subsequent laboratory, imaging, and genetic testing [15].

Additional Diagnostic Tests

  • Genetic testing
  • Blood or urine tests
  • Electrophysiological tests

Treatment

Myoclonic dystonia (M-D) is a rare movement disorder characterized by involuntary muscle contractions and spasms, often accompanied by dystonic movements. The treatment of M-D typically involves a combination of medications and other therapies.

Medications

Several oral medications have been used to treat M-D, with varying degrees of success [3]. These include:

  • Benzodiazepines (clonazepam, lorazepam, diazepam) [3]
  • Valproic acid [3]
  • Gabapentin [3]
  • Trihexyphenidyl is the most frequently employed medication for dystonia in adults and children with generally good efficacy and overall good safety profile at therapeutic doses [2]

Deep Brain Stimulation

In some cases, deep brain stimulation (DBS) may be considered as a treatment option for M-D. DBS involves implanting an electrode in a specific area of the brain to stimulate it and reduce symptoms.

Other Therapies

Complementary therapies such as physical therapy, occupational therapy, and speech therapy may also be beneficial in managing the symptoms of M-D [5].

It's worth noting that there is presently no effective drug for this disease, but DBS gives good results, although it is invasive [7]. Levetiracetam and Piracetam (outside the US) are also used as first-line therapies [8], while clonazepam and valproic acid are alternatives and add-on therapies [8].

References:

[1] AY Luciano · 2014 · Cited by 42 — [2] by C Fearon · 2020 · Cited by 14 — [3] by AY Luciano · 2014 · Cited by 42 — [5] A disorder characterized by dystonia and myonlonus symptoms · [7] Apr 8, 2016 — [8] by JN Caviness · Cited by 120 —

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for myoclonus-dystonia (M-D) involves ruling out other conditions that may present with similar symptoms.

According to the medical literature, one condition that can be difficult to distinguish from M-D is Epilepsy-Associated Myoclonia Type 2 (EPM2). EPM2 patients often experience frequent generalized seizures that are challenging to control [7].

Another condition that may be considered in the differential diagnosis of M-D is Epilepsy-Associated Myoclonia Type 1 (EPM1), although it's worth noting that the differential diagnosis between EPM1 and EPM2 is relatively straightforward, as EPM2 patients tend to have more severe seizure activity [7].

In addition to these conditions, other potential differential diagnoses for M-D may include:

  • Other movement disorders, such as essential tremor or Parkinson's disease
  • Neurodegenerative diseases, such as Huntington's disease or amyotrophic lateral sclerosis (ALS)
  • Metabolic disorders, such as hypokalemia or hyperthyroidism

It's worth noting that the diagnosis of M-D is typically based on a combination of family history, physical and neurological examination, and laboratory tests [9].

References: [7] by A Riva · 2024 · Cited by 6 [9] by T Popa · 2014 · Cited by 61

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0090036
core#notation
DOID:0090036
oboInOwl#hasDbXref
MIM:616398
rdf-schema#label
myoclonic dystonia 26
IAO_0000115
A myoclonic dystonia characterized by onset of myoclonic jerks affecting the upper limbs, progressing to dystonia with predominant involvement of the craniocervical regions, and has_material_basis_in autosomal dominant inheritance of heterozygous mutation in the KCTD17 gene on chromosome 22q12.
rdf-schema#subClassOf
t361571
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_4249
owl#annotatedSource
t361647

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.